Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Jun;87(11):4112–4114. doi: 10.1073/pnas.87.11.4112

Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo.

J Rauch 1, A S Janoff 1
PMCID: PMC54057  PMID: 2112249

Abstract

Immunization of mice with phosphatidylethanolamine in the hexagonal II phase but not the bilayer phase resulted in the induction of anti-phospholipid antibodies. These antibodies, which were strongly reactive with phosphatidylethanolamine and crossreactive with cardiolipin, had functional lupus anticoagulant activity and were characteristic of autoantibodies common in patients with autoimmune disease. Recognition of the hexagonal II phase by the afferent limb of the immune system suggests that nonbilayer phospholipids can arise in the course of membrane remodeling and induce the autoantibodies of disease.

Full text

PDF
4112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alving B. M., Banerji B., Fogler W. E., Alving C. R. Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate. Clin Exp Immunol. 1987 Aug;69(2):403–408. [PMC free article] [PubMed] [Google Scholar]
  2. Alving C. R. Antibodies to liposomes, phospholipids and phosphate esters. Chem Phys Lipids. 1986 Jun-Jul;40(2-4):303–314. doi: 10.1016/0009-3084(86)90075-7. [DOI] [PubMed] [Google Scholar]
  3. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  4. Colaco C. B., Elkon K. B. The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum. 1985 Jan;28(1):67–74. doi: 10.1002/art.1780280111. [DOI] [PubMed] [Google Scholar]
  5. Cullis P. R., Hope M. J., Tilcock C. P. Lipid polymorphism and the roles of lipids in membranes. Chem Phys Lipids. 1986 Jun-Jul;40(2-4):127–144. doi: 10.1016/0009-3084(86)90067-8. [DOI] [PubMed] [Google Scholar]
  6. Eilat D., Zlotnick A. Y., Fischel R. Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals. Clin Exp Immunol. 1986 Aug;65(2):269–278. [PMC free article] [PubMed] [Google Scholar]
  7. Exner T., Rickard K. A., Kronenberg H. Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology. 1975 Oct;7(4):319–328. doi: 10.3109/00313027509081688. [DOI] [PubMed] [Google Scholar]
  8. FRICK P. G. Acquired circulating anticoagulants in systemic collagen disease; auto-immune thromboplastin deficiency. Blood. 1955 Jul;10(7):691–706. [PubMed] [Google Scholar]
  9. Feinstein D. I., Rapaport S. I. Acquired inhibitors of blood coagulation. Prog Hemost Thromb. 1972;1:75–95. [PubMed] [Google Scholar]
  10. Harris E. N., Gharavi A. E., Boey M. L., Patel B. M., Mackworth-Young C. G., Loizou S., Hughes G. R. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 Nov 26;2(8361):1211–1214. doi: 10.1016/s0140-6736(83)91267-9. [DOI] [PubMed] [Google Scholar]
  11. Harris E. N., Gharavi A. E., Hughes G. R. Anti-phospholipid antibodies. Clin Rheum Dis. 1985 Dec;11(3):591–609. [PubMed] [Google Scholar]
  12. Harris E. N., Loizou S., Englert H., Derue G., Chan J. K., Gharavi A. E., Hughes G. R. Anticardiolipin antibodies and lupus anticoagulant. Lancet. 1984 Nov 10;2(8411):1099–1099. doi: 10.1016/s0140-6736(84)91537-x. [DOI] [PubMed] [Google Scholar]
  13. Hazeltine M., Rauch J., Danoff D., Esdaile J. M., Tannenbaum H. Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol. 1988 Jan;15(1):80–86. [PubMed] [Google Scholar]
  14. Ichikawa K., Shimada K., Nawata Y., Ishii T., Tomioka H., Yoshida S., Koike T. Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice. Clin Exp Immunol. 1988 Oct;74(1):110–114. [PMC free article] [PubMed] [Google Scholar]
  15. Janoff A. S., Rauch J. The structural specificity of anti-phospholipid antibodies in autoimmune disease. Chem Phys Lipids. 1986 Jun-Jul;40(2-4):315–332. doi: 10.1016/0009-3084(86)90076-9. [DOI] [PubMed] [Google Scholar]
  16. Kelsey P. R., Stevenson K. J., Poller L. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine. Thromb Haemost. 1984 Oct 31;52(2):172–175. [PubMed] [Google Scholar]
  17. Killian J. A., de Kruijff B. The influence of proteins and peptides on the phase properties of lipids. Chem Phys Lipids. 1986 Jun-Jul;40(2-4):259–284. doi: 10.1016/0009-3084(86)90073-3. [DOI] [PubMed] [Google Scholar]
  18. Lafer E. M., Rauch J., Andrzejewski C., Jr, Mudd D., Furie B., Furie B., Schwartz R. S., Stollar B. D. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med. 1981 Apr 1;153(4):897–909. doi: 10.1084/jem.153.4.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lechner K. Acquired inhibitors in nonhemophilic patients. Haemostasis. 1974;3(2):65–93. doi: 10.1159/000214043. [DOI] [PubMed] [Google Scholar]
  20. Lockshin M. D. Anticardiolipin antibody. Arthritis Rheum. 1987 Apr;30(4):471–472. doi: 10.1002/art.1780300420. [DOI] [PubMed] [Google Scholar]
  21. MARGOLIUS A., Jr, JACKSON D. P., RATNOFF O. D. Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine (Baltimore) 1961 May;40:145–202. [PubMed] [Google Scholar]
  22. Marcus D. M., Schwarting G. A. Immunochemical properties of glycolipids and phospholipids. Adv Immunol. 1976;23:203–240. [PubMed] [Google Scholar]
  23. Rauch J., Tannenbaum H., Stollar B. D., Schwartz R. S. Monoclonal anti-cardiolipin antibodies bind to DNA. Eur J Immunol. 1984 Jun;14(6):529–534. doi: 10.1002/eji.1830140609. [DOI] [PubMed] [Google Scholar]
  24. Rauch J., Tannenbaum M., Janoff A. S. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost. 1989 Nov 24;62(3):892–896. [PubMed] [Google Scholar]
  25. Rauch J., Tannenbaum M., Tannenbaum H., Ramelson H., Cullis P. R., Tilcock C. P., Hope M. J., Janoff A. S. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem. 1986 Jul 25;261(21):9672–9677. [PubMed] [Google Scholar]
  26. Schleider M. A., Nachman R. L., Jaffe E. A., Coleman M. A clinical study of the lupus anticoagulant. Blood. 1976 Oct;48(4):499–509. [PubMed] [Google Scholar]
  27. Smeenk R. J., Lucassen W. A., Swaak T. J. Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum. 1987 Jun;30(6):607–617. doi: 10.1002/art.1780300602. [DOI] [PubMed] [Google Scholar]
  28. Thiagarajan P., Shapiro S. S., De Marco L. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest. 1980 Sep;66(3):397–405. doi: 10.1172/JCI109869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tilcock C. P., Cullis P. R., Hope M. J., Gruner S. M. Polymorphic phase behavior of unsaturated lysophosphatidylethanolamines: a 31P NMR and X-ray diffraction study. Biochemistry. 1986 Feb 25;25(4):816–822. doi: 10.1021/bi00352a013. [DOI] [PubMed] [Google Scholar]
  30. Tilcock C. P. Lipid polymorphism. Chem Phys Lipids. 1986 Jun-Jul;40(2-4):109–125. doi: 10.1016/0009-3084(86)90066-6. [DOI] [PubMed] [Google Scholar]
  31. Triplett D. A., Brandt J. T., Musgrave K. A., Orr C. A. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA. 1988 Jan 22;259(4):550–554. [PubMed] [Google Scholar]
  32. Veltkamp J. J., Kerkhoven P., Loeliger E. A. Circulating anticoagulant in disseminated lupus erythematosus. Proposed mode of action. Haemostasis. 1973;2(6):253–259. doi: 10.1159/000214029. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES